Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Yiqi Wenyang Jiedu Prescription in the Prevention and Treatment of Postoperative Metastasis and Recurrence of Gastric Cancer：A Randomized, Double-blind, Controlled and Multi-center Clinical Study

NCT05229809 is registered in ClinicalTrials.gov with Jie Li as lead sponsor.

NCT NCT05229809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05229809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Yiqi Wenyang Jiedu Prescription in the Prevention and Treatment of Postoperative Metastasis and Recurrence of Gastric Cancer：A Randomized, Double-blind, Controlled and Multi-center Clinical Study
Lead sponsor
Jie Li
Phase
Phase 4
Overall status
Unknown status
Start date
March 1, 2022
Completion date
July 31, 2024
Enrollment
212 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

gastric carcinoma